Pilar Oubiña
Complutense University of Madrid
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Pilar Oubiña.
Kidney International | 2008
Victoria Cachofeiro; Marian Goicochea; Soledad García de Vinuesa; Pilar Oubiña; Vicente Lahera; José Luño
Patients with chronic kidney disease (CKD) show a high cardiovascular morbidity and mortality. This seems to be consequence of the cardiovascular risk factor clustering in CKD patients. Non traditional risk factors such as oxidative stress and inflammation are also far more prevalent in this population than in normal subjects. Renal disease is associated with a graded increase in oxidative stress markers even in early CKD. This could be consequence of an increase in reactive oxygen species as well as a decrease in antioxidant defence. This oxidative stress can accelerate renal injury progression. Inflammatory markers such as C reactive protein and cytokines increase with renal function deterioration suggesting that CKD is a low-grade inflammatory process. In fact, inflammation facilitates renal function deterioration. Several factors can be involved in triggering the inflammatory process including oxidative stress. Statin administration is accompanied by risk reduction in all major vascular events in patients with CKD that are considered high-risk patients. These beneficial effects seem to be consequence of not only their hypolipidemic effect but especially their pleitropic actions that involve modulation of oxidative stress and inflammation.
British Journal of Nutrition | 2001
Pilar Oubiña; Francisco J. Sánchez-Muniz; Sofía Ródenas; Carmen Cuesta
The present paper compares the effects of two monounsaturated oils, extra virgin olive oil (EVOO) and high-oleic acid sunflower oil (HOSO), on serum and LDL peroxides, eicosanoid production and the thrombogenic ratio (thromboxane (TX) B2:6-keto-prostaglandin F1alpha) in fourteen non-obese post-menopausal women. The subjects, mean age 63 (SD 11) years, were assigned to two consecutive oleic acid-rich 28 d dietary periods. EVOO and HOSO represented 62 % of the total lipid intake and were used as the only culinary fat during the first and second dietary periods respectively. Serum peroxides, plasma alpha-tocopherol and TXB2 levels in stimulated platelet-rich plasma (PRP-TXB2) were significantly higher (P < 0.01, P < 0.001, and P < 0.05, respectively) after the HOSO diet than after the EVOO diet. The relationship between the serum cholesterol level (< 6.21 mmol/l or > or = 6.21 mmol/l) and the type of dietary oil on eicosanoids, peroxides and alpha-tocopherol were evaluated by two-way ANOVA. Dietary oil significantly affected (P < 0.05) the PRP-TXB2 level, whereas serum and LDL peroxides were significantly affected (P < 0.001 and P < 0.01, respectively) by the serum cholesterol level. The plasma alpha-tocopherol level was significantly affected by the serum cholesterol level and the type of dietary oil (both P < 0.001). No significant relationships were found between serum cholesterol levels, serum peroxide or LDL peroxide levels, plasma alpha-tocopherol concentrations or alpha-tocopherol intakes with eicosanoid production or the thrombogenic ratio due to dietary changes. However, in spite of their higher alpha-tocopherol levels, hypercholesterolaemic subjects showed increased peroxidation in serum and LDL in comparison with normocholesterolaemic subjects on the HOSO diet in comparison with the EVOO diet. These findings suggest that differences in the type of minor compounds, as well as in the concentration of linoleic acid, in both these monounsaturated oils may play an important role in modulating eicosanoid production and lipoprotein peroxidation when they constitute a large proportion of the diet of post-menopausal women.
Mediators of Inflammation | 2013
Diego Gómez-Arbeláez; Vicente Lahera; Pilar Oubiña; María Valero-Muñoz; Natalia de las Heras; Yudy A. Rodríguez; Ronald G. Garcia; Paul Anthony Camacho; Patricio López-Jaramillo
Background. Garlic (Allium sativum) has been shown to have important benefits in individuals at high cardiovascular risk. The aim of the present study was to evaluate the effects of the administration of aged garlic extract (AGE) on the risk factors that constitute the cluster of metabolic syndrome (MS). Methods and Design. Double-blind, crossover, randomized, placebo-controlled clinical trial to assess the effect of 1.2 g/day of AGE (Kyolic), for 24 weeks of treatment (12 weeks of AGE and 12 weeks of placebo), on subjects with MS. Results. The administration of AGE increased the plasma levels of adiponectin (P = 0.027). No serious side effects associated with the intervention were reported. Conclusion. The present results have shown for the first time that the administration of AGE for 12 weeks increased plasma adiponectin levels in patients with MS. This suggests that AGE might be a useful, novel, nonpharmacological therapeutic intervention to increase adiponectin and to prevent cardiovascular (CV) complications in individuals with MS.
Hipertensión y Riesgo Vascular | 2009
D. Sanz-Rosa; E. Cediel; N. de las Heras; María Miana; Pilar Oubiña; Vicente Lahera; Victoria Cachofeiro
Objetives To study the participation of aldosterone in the vascular dysfunction, inflammatory process and vascular oxidative stress associated to hypertension.
Journal of Nutrition | 2004
Stefanie Schoppen; Ana M. Pérez-Granados; A. Carbajal; Pilar Oubiña; Francisco J. Sánchez-Muniz; Juan A. Gómez-Gerique; M. Pilar Vaquero
Journal of The American Society of Nephrology | 2006
Vicente Lahera; Marian Goicoechea; Soledad García de Vinuesa; Pilar Oubiña; Victoria Cachofeiro; Francisco Gómez-Campderá; Raquel Amann; José Luño
Journal of the American Oil Chemists' Society | 1998
Francisco J. Sánchez-Muniz; Pilar Oubiña; Juana Benedí; Sofía Ródenas; C. Cuesta
European Journal of Nutrition | 2003
Francisco J. Sánchez-Muniz; Pilar Oubiña; Sofía Ródenas; Juana Benedí; Carmen Cuesta
Hypertension | 2000
F Victoria Cachofeiro; Pilar Oubiña; Natalia de las Heras; S. Vázquez-Pérez; Josefa Navarro-Cid; Eva Cediel; David Sanz-Rosa; Marc de Gasparo; Luis M. Ruilope; Vicente Lahera
Journal of Hypertension | 2004
E. Cediel; María Miana; D. Sanz-Rosa; N. de las Heras; Pilar Oubiña; Victoria Cachofeiro; Vicente Lahera